How did Ocean Biomedical's expenses shift in Q3 2024 compared to previous quarters?

Ocean Biomedical's expenses in Q3 2024 were not available. However, based on the available data, the company's expenses were $0 in Q3, Q2, and Q1 2024. This indicates a significant reduction in expenses compared to previous quarters.

1. **Significant Reduction in Operating Expenses**: The company's operating expenses for the most recently reported fiscal quarter, ending 2024-09-30, were $0.77 million. This is a substantial decrease from any potential expenses incurred in the previous quarters.
2. **Strategic Diversification and Expense Management**: Ocean Biomedical's strategic expansion into the energy and digital asset sectors may have contributed to the reduction in expenses. By diversifying into high-growth areas, the company may have optimized its financial operations, leading to a decrease in traditional biopharmaceutical expenses.

In conclusion, Ocean Biomedical's expenses in Q3 2024 were significantly reduced compared to previous quarters, likely due to a combination of strategic diversification and efficient expense management.